cytokine storm

You have access
Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19
ALICE G. VASSILIOU, IOANNA DIMOPOULOU, EDISON JAHAJ, CHRYSI KESKINIDOU, ZAFEIRIA MASTORA, STYLIANOS E. ORFANOS and ANASTASIA KOTANIDOU

In Vivo March 2021, 35 (2) 1295-1298; DOI: https://doi.org/10.21873/invivo.12381
You have access
Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy
BETTE S. POLLARD, JORGE C. BLANCOl and JOHN R. POLLARD

In Vivo November 2020, 34 (6) 3723-3730; DOI: https://doi.org/10.21873/invivo.12221
You have access
Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality
KAREL SMETANA, DANIEL ROSEL and JAN BRÁBEK

In Vivo September 2020, 34 (5) 3027-3028; DOI: https://doi.org/10.21873/invivo.12135
You have access
Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications
KAREL SMETANA and JAN BRÁBEK

In Vivo June 2020, 34 (3 suppl) 1589-1592; DOI: https://doi.org/10.21873/invivo.11947
You have access
Curcumin Suppression of Cytokine Release and Cytokine Storm. A Potential Therapy for Patients with Ebola and Other Severe Viral Infections
PETER P. SORDILLO and LAWRENCE HELSON

In Vivo January 2015, 29 (1) 1-4;

Main menu